Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × irinotecan sucrosofate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 35 Colorectal Neoplasms 16 Small Cell Lung Carcinoma 8 Neoplasms 8 Stomach Neoplasms 7 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Recurrence 3 Rectal Neoplasms 3 Osteosarcoma 3 Cholangiocarcinoma 3 Triple Negative Breast Neoplasms 2 Solid Tumor 2 Neuroblastoma 2 Nasopharyngeal Carcinoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Wilms Tumor 1 Weight Loss 1 Somatostatinoma 1 Solid Tumor Cancer 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Refractory Solid Tumors 1

Interventions

Cisplatin 72 Radiotherapy 41 pembrolizumab 36 Cetuximab 34 Paclitaxel 32 Carboplatin 32 Docetaxel 28 Radiotherapy, Intensity-Modulated 22 Fluorouracil 22 Nivolumab 15 Drug Therapy 14 Radiation 12 cemiplimab 8 Erlotinib Hydrochloride 8 Blood Specimen Collection 8 130-nm albumin-bound paclitaxel 8 durvalumab 7 atezolizumab 6 Surveys and Questionnaires 6 Panitumumab 6 Esophagectomy 6 Afatinib 6 Surgical Procedures, Operative 5 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Gemcitabine 5 Cyclophosphamide 5 Chemoradiotherapy 5 Capecitabine 5 Albumin-Bound Paclitaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03719924 2025-01-08

OESIRI

Federation Francophone de Cancerologie Digestive

Phase 2 Completed

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡